TSX News -
VBI Vaccines Reports Positive Outcome from Phase III Pre-IND Discussions with the FDA for Hepatitis B Vaccine, Sci-B-Vac(TM)
CAMBRIDGE, MASSACHUSETTS–(Marketwired – June 19, 2017) – VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) (“VBI”), a commercial-stage biopharmaceutical company developing [...]